In the ever-evolving battle against antibiotic resistance, the emergence of new antibiotics offers a glimmer of hope for eradicating drug-resistant infections.Kinvard Bio, a pioneering biotechnology startup launched by Harvard scientists, is at the forefront of this fight, working to create innovative compounds that effectively address the challenges posed by bacteria that have adapted to existing treatments.